These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 15186519)

  • 1. Development of a novel human immunodeficiency virus type 1 subtyping tool, Subtype Analyzer (STAR): analysis of subtype distribution in London.
    Gale CV; Myers R; Tedder RS; Williams IG; Kellam P
    AIDS Res Hum Retroviruses; 2004 May; 20(5):457-64. PubMed ID: 15186519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-resistant reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAART.
    Caride E; Brindeiro R; Hertogs K; Larder B; Dehertogh P; Machado E; de Sá CA; Eyer-Silva WA; Sion FS; Passioni LF; Menezes JA; Calazans AR; Tanuri A
    Virology; 2000 Sep; 275(1):107-15. PubMed ID: 11017792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools.
    Pineda-Peña AC; Faria NR; Imbrechts S; Libin P; Abecasis AB; Deforche K; Gómez-López A; Camacho RJ; de Oliveira T; Vandamme AM
    Infect Genet Evol; 2013 Oct; 19():337-48. PubMed ID: 23660484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability of rapid subtyping tools compared to that of phylogenetic analysis for characterization of human immunodeficiency virus type 1 non-B subtypes and recombinant forms.
    Holguín A; López M; Soriano V
    J Clin Microbiol; 2008 Dec; 46(12):3896-9. PubMed ID: 18842935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Evaluation of Subtyping Tools for Surveillance of Newly Emerging HIV-1 Strains.
    Fabeni L; Berno G; Fokam J; Bertoli A; Alteri C; Gori C; Forbici F; Takou D; Vergori A; Zaccarelli M; Maffongelli G; Borghi V; Latini A; Pennica A; Mastroianni CM; Montella F; Mussini C; Andreoni M; Antinori A; Perno CF; Santoro MM;
    J Clin Microbiol; 2017 Sep; 55(9):2827-2837. PubMed ID: 28701420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleotide and amino acid polymorphisms at drug resistance sites in non-B-subtype variants of human immunodeficiency virus type 1.
    Turner D; Brenner B; Moisi D; Detorio M; Cesaire R; Kurimura T; Mori H; Essex M; Maayan S; Wainberg MA
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2993-8. PubMed ID: 15273111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the reverse transcriptase of a human immunodeficiency virus type 1 group O isolate.
    Quiñones-Mateu ME; Soriano V; Domingo E; Menéndez-Arias L
    Virology; 1997 Sep; 236(2):364-73. PubMed ID: 9325244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A statistical model for HIV-1 sequence classification using the subtype analyser (STAR).
    Myers RE; Gale CV; Harrison A; Takeuchi Y; Kellam P
    Bioinformatics; 2005 Sep; 21(17):3535-40. PubMed ID: 16046498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of drug resistance sequence data for the systematic detection of non-B human immunodeficiency virus type 1 (HIV-1) subtypes: how to create a sentinel site for monitoring the genetic diversity of HIV-1 at a country scale.
    Yahi N; Fantini J; Tourres C; Tivoli N; Koch N; Tamalet C
    J Infect Dis; 2001 May; 183(9):1311-7. PubMed ID: 11294661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV type 1 pol gene diversity and archived nevirapine resistance mutation in pregnant women in Rwanda.
    Servais J; Lambert C; Karita E; Vanhove D; Fischer A; Baurith T; Schmit JC; Schneider F; Hemmer R; Arendt V
    AIDS Res Hum Retroviruses; 2004 Mar; 20(3):279-83. PubMed ID: 15117451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 primary and secondary antiretroviral drug resistance and genetic diversity among pregnant women from central Brazil.
    Cardoso LP; Pereira GA; Viegas AA; Schmaltz LE; Stefani MM
    J Med Virol; 2010 Mar; 82(3):351-7. PubMed ID: 20087934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance.
    Buckton AJ; Bissett SL; Myers RE; Beddows S; Edwards S; Cane PA; Pillay D
    J Antimicrob Chemother; 2008 Dec; 62(6):1191-8. PubMed ID: 18927229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of antiretroviral resistance in treated Ugandans infected with non-subtype B human immunodeficiency virus type 1.
    Richard N; Juntilla M; Abraha A; Demers K; Paxinos E; Galovich J; Petropoulos C; Whalen CC; Kyeyune F; Atwine D; Kityo C; Mugyenyi P; Arts EJ
    AIDS Res Hum Retroviruses; 2004 Apr; 20(4):355-64. PubMed ID: 15157354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of a genotypic assay applicable to all human immunodeficiency virus type 1 protease and reverse transcriptase subtypes.
    Snoeck J; Riva C; Steegen K; Schrooten Y; Maes B; Vergne L; Van Laethem K; Peeters M; Vandamme AM
    J Virol Methods; 2005 Sep; 128(1-2):47-53. PubMed ID: 15871907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism in HIV-1 non-subtype B protease and reverse transcriptase and its potential impact on drug susceptibility and drug resistance evolution.
    Kantor R; Katzenstein D
    AIDS Rev; 2003; 5(1):25-35. PubMed ID: 12875105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural polymorphism in protease and reverse transcriptase genes and in vitro antiretroviral drug susceptibilities of non-B HIV-1 strains from treatment-naive patients.
    Vergne L; Stuyver L; Van Houtte M; Butel C; Delaporte E; Peeters M
    J Clin Virol; 2006 May; 36(1):43-9. PubMed ID: 16563858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immunodeficiency virus-1 subtypes and antiretroviral drug resistance profiles among drug-naïve Brazilian blood donors.
    Sá-Ferreira JA; Brindeiro PA; Chequer-Fernandez S; Tanuri A; Morgado MG
    Transfusion; 2007 Jan; 47(1):97-102. PubMed ID: 17207236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: results from the DREAM programme.
    Bellocchi MC; Forbici F; Palombi L; Gori C; Coelho E; Svicher V; D'Arrigo R; Emberti-Gialloreti L; Ceffa S; Erba F; Marazzi MC; Silberstein FC; Perno CF
    J Med Virol; 2005 Aug; 76(4):452-8. PubMed ID: 15977236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High incidence of non-B and recombinant HIV-1 strains in newly diagnosed patients in Galicia, Spain: study of genotypic resistance.
    Pérez-Alvarez L; Carmona R; Muñoz M; Delgado E; Thomson MM; Contreras G; Pedreira JD; Rodríguez Real R; Vázquez de Parga E; Medrano L; Taboada JA; Nájera R;
    Antivir Ther; 2003 Aug; 8(4):355-60. PubMed ID: 14518705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 subtypes in Spain: a retrospective analysis from 1995 to 2003.
    Lospitao E; Alvarez A; Soriano V; Holguín A
    HIV Med; 2005 Sep; 6(5):313-20. PubMed ID: 16156878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.